Injection of the specific superoxide radical scavenger SOD 58 d after infection in conjugation with a pyran copolymer protects mice against lethal influenza virus infection 73 , thus suggesting that it has therapeutic potential against influenza virus infection
19 While these offer more than a ten-fold increase in F over permeation enhancer-based systems, they have their own issues in terms of reliability of activation at the gut wall, safety, and an uncertain regulatory pathway
To summarize several meta-analyses of CVOTs conducted with GLP-1RAs, it isconfirmed that based on 43 trials, GLP-1RAs are a class of efficacious agent for reducing MACE (MH-OR 0.87 [0.83, 0.92]), cardiovascular and all-cause mortality (MH-OR 0.89 [0.83, 0.96]) [48]
Steve Kates, a longtime pharmaceutical executive and expert in peptide design and manufacturing, said one of the chief concerns with some of these peptides is that they have not undergone rigorous, long-term testing typically consistent with FDA-approved medications
